Advertisement

Archives of Virology

, 156:1803 | Cite as

Identification of amino acids in highly pathogenic avian influenza H5N1 virus hemagglutinin that determine avian influenza species specificity

  • Zheng Li
  • Zhonghua Liu
  • Chi Ma
  • Linqi Zhang
  • Yuelong Su
  • George F. Gao
  • Zi Li
  • Lianxian Cui
  • Wei HeEmail author
Original Article

Abstract

To test the role of neutralizing antibodies (nAbs) and receptor adaptation in interspecies transmission of influenza virus, two H5N1 strains, isolated from human and avian hosts, with four amino acid differences in hemagglutinin (HA) and seven HA mutations were studied. We found that a mutation at amino acid position 90 in the H5N1 HA, outside the receptor-binding domain (RBD), could simultaneously induce changes in the RBD conformation to escape from nAb binding and alter the receptor preference through long-range regulation. This mutation was deemed a “key event” for interspecies transmission. It is likely a result of positive selection caused by antibodies, allowing the original invasion by new species-specific variants. A mutation at amino acid position 160 in the RBD only induced a change in receptor preference. This mutation was deemed a “maintaining adaptation”, which ensured that influenza virus variants would be able to infect new organisms of a different species successfully. The mutation is the result of adaptation caused by the receptor. Our results suggest that continuing occurrence of these two types of mutations made the variants persist in the new host species.

Keywords

Influenza Virus Sialic Acid Avian Influenza Avian Influenza Virus Highly Pathogenic Avian Influenza 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

HPAI

Highly pathogenic avian influenza

HA

Hemagglutinin

RBD

Receptor binding domain

SA

Sialic acid

Notes

Acknowledgments

We thank Dr. Wenhui Li for his kind help in the pseudotype neutralization. This work is funded by National Institutes of Health (NIH) [grant numbers U19 AI051915-05S1].

Supplementary material

705_2011_1056_MOESM1_ESM.tif (1.4 mb)
Supplementary Fig. S1 (TIFF 1420 kb)

References

  1. 1.
    Burton DR (2002) Antibodies, viruses and vaccines. Nature 2:706–713Google Scholar
  2. 2.
    Chandrasekaran A, Srinivasan A, Raman R, Viswanathan K, Raguram S, Tumpey TM, Sasisekharan V, Sasisekharan R (2008) Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol 26:107–113PubMedCrossRefGoogle Scholar
  3. 3.
    Gao Y, Zhang Y, Shinya K, Deng G, Jiang Y, Li Z, Guan Y, Tian G, Li Y, Shi J, Liu L, Zeng X, Bu Z, Xia X, Kawaoka Y, Chen H (2009) Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog 5:e1000709PubMedCrossRefGoogle Scholar
  4. 4.
    Guo CT, Takahashi N, Yagi H, Kato K, Takahashi T, Yi SQ, Chen Y, Ito T, Otsuki K, Kida H, Kawaoka Y, Hidari KI, Miyamoto D, Suzuki T, Suzuki Y (2007) The quail and chicken intestine have sialyl-galactose sugar chains responsible for the binding of influenza A viruses to human type receptors. Glycobiology 17:713–724PubMedCrossRefGoogle Scholar
  5. 5.
    Hangartner L, Zinkernagel RM, Hengartner H (2006) Antiviral antibody responses: the two extremes of a wild spectrum. Nat Rev Immunol 6:231–241PubMedCrossRefGoogle Scholar
  6. 6.
    Hensley SE, Das SR, Bailey AL, Schmidt LM, Hickman HD, Jayaraman A, Viswanathan K, Raman R, Sasisekharan R, Bennink JR, Yewdell JW (2009) Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 326:734–736PubMedCrossRefGoogle Scholar
  7. 7.
    He Y, Li J, Jiang S (2006) A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity. Biochem Biophys Res Commun 344:106–113PubMedCrossRefGoogle Scholar
  8. 8.
    Karlsson Hedestam GB, Fouchier RA, Phogat S, Burton DR, Sodroski J, Wyatt RT (2008) The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat Rev Microbiol 6:143–155PubMedCrossRefGoogle Scholar
  9. 9.
    Khurana S, Suguitan AL Jr, Rivera Y, Simmons CP, Lanzavecchia A, Sallusto F, Manischewitz J, King LR, Subbarao K, Golding H (2009) Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med 6:e100049CrossRefGoogle Scholar
  10. 10.
    Kuiken T, Holmes EC, McCauley J, Rimmelzwaan GF, Williams CS, Grenfell BT (2006) Host species barriers to influenza virus infections. Science 21:394–397CrossRefGoogle Scholar
  11. 11.
    Liu J, Xiao H, Lei F, Zhu Q, Qin K, Zhang XW, Zhang XL, Zhao D, Wang G, Feng Y, Ma J, Liu W, Wang J, Gao GF (2005) Highly pathogenic H5N1 influenza virus infection in migratory birds. Science 309:1206PubMedCrossRefGoogle Scholar
  12. 12.
    Li Z, Ma C, Liu Z, He W (2011) Serologic cross-reactivity among humans and birds infected with highly pathogenic avian influenza A subtype H5N1 viruses in China. Immunol Lett 135:59–63PubMedCrossRefGoogle Scholar
  13. 13.
    Luo W, Chen Y, Wang M, Chen Y, Zheng Z, Song H, Chen H, Guan Y, Ng MH, Zhang J, Xia N (2009) Peptide mimics of a conserved H5N1 avian influenza virus neutralization site. Biochem J 419:133–139PubMedCrossRefGoogle Scholar
  14. 14.
    Marasco WA, Sui J (2007) The growth and potential of human antiviral monoclonal antibody therapeutics. Nature Biotechnol 25:1421–1434CrossRefGoogle Scholar
  15. 15.
    Martinez O, Tsibane T, Basler CF (2009) Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tool for discovery. Int Rev Immunol 28:69–92PubMedCrossRefGoogle Scholar
  16. 16.
    Nakajima S, Nakajima K, Nobusawa E, Zhao J, Tanaka S, Fukuzawa K (2007) Comparison of epitope structures of H3HAs through protein modeling of influenza A virus hemagglutinin: mechanism for selection of antigenic variants in the presence of a monoclonal antibody. Microbiol Immunol 51:1179–1187PubMedGoogle Scholar
  17. 17.
    Ndifon W, Wingreen NS, Levin SA (2009) Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines. PNAS 106:8701–8706PubMedCrossRefGoogle Scholar
  18. 18.
    Nelson MI, Holmes EC (2007) The evolution of epidemic influenza. Nature 8:196–205Google Scholar
  19. 19.
    Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, Kwong DL, Wong MP, Chui WH, Poon LL, Tsao SW, Guan Y, Peiris JS (2007) Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 13:147–149PubMedCrossRefGoogle Scholar
  20. 20.
    Pinschewer DD, Perez M, Jeetendra E, Bächi T, Horvath E, Hengartner H, Whitt MA, de la Torre JC, Zinkernagel RM (2004) Kinetics of protective antibodies are determined by the viral surface antigen. J Clin Invest 114:988–993PubMedGoogle Scholar
  21. 21.
    Shih AC, Hsiao TC, Ho MS, Li WH (2007) Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. PNAS 104:6283–6288PubMedCrossRefGoogle Scholar
  22. 22.
    Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y (2006) Avian flu: influenza virus receptors in the human airway. Nature 440:435–436PubMedCrossRefGoogle Scholar
  23. 23.
    Skehel JJ, Wiley DC (2000) Receptor binding and membrane fusion in virus entry: the Influenza hemagglutinin. Annu Rev Biochem 69:531–569PubMedCrossRefGoogle Scholar
  24. 24.
    Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA (2006) Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404–410PubMedCrossRefGoogle Scholar
  25. 25.
    Sui J, Aird DR, Tamin A, Murakami A, Yan M, Yammanuru A, Jing H, Kan B, Liu X, Zhu Q, Yuan QA, Adams GP, Bellini WJ, Xu J, Anderson LJ, Marasco WA (2008) Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway. PLoS Pathog 4:e1000197PubMedCrossRefGoogle Scholar
  26. 26.
    Sui J, Hwang WC, Perez S, Wei G, Aird D, Chen LM, Santelli E, Stec B, Cadwell G, Ali M, Wan H, Murakami A, Yammanuru A, Han T, Cox NJ, Bankston LA, Donis RO, Liddington RC, Marasco WA (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16:265–273PubMedCrossRefGoogle Scholar
  27. 27.
    Suzuki Y (2006) Natural selection on the influenza virus genome. Mol Biol Evol 23:1902–1911PubMedCrossRefGoogle Scholar
  28. 28.
    Takematsu K, Fukuzawa K, Omagari K, Nakajima S, Nakajima K, Mochizuki Y, Nakano T, Watanabe H, Tanaka S (2009) Possibility of mutation prediction of influenza hemagglutinin by combination of hemadsorption experiment and quantum chemical calculation for antibody binding. J Phys Chem B 113:4991–4994PubMedCrossRefGoogle Scholar
  29. 29.
    Totani K, Kubota T, Kuroda T, Murata T, Hidari KI, Suzuki T, Suzuki Y, Kobayashi K, Ashida H, Yamamoto K, Usui T (2003) Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly (L-glutamic acid) backbone for inhibition of infection by influenza viruses. Glycobiology 13:315–326PubMedCrossRefGoogle Scholar
  30. 30.
    Yang ZY, Wei CJ, Kong WP, Wu L, Xu L, Smith DF, Nabel GJ (2007) Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. Science 317:825–828PubMedCrossRefGoogle Scholar
  31. 31.
    Yamada S, Suzuki Y, Suzuki T, Le MQ, Nidom CA, Sakai-Tagawa Y, Muramoto Y, Ito M, Kiso M, Horimoto T, Shinya K, Sawada T, Kiso M, Usui T, Murata T, Lin Y, Hay A, Haire LF, Stevens DJ, Russell RJ, Gamblin SJ, Skehel JJ, Kawaoka Y (2006) Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444:378–382PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Zheng Li
    • 1
  • Zhonghua Liu
    • 2
  • Chi Ma
    • 1
  • Linqi Zhang
    • 2
  • Yuelong Su
    • 3
  • George F. Gao
    • 4
  • Zi Li
    • 3
  • Lianxian Cui
    • 1
  • Wei He
    • 1
    Email author
  1. 1.The Department of Immunology, Institute of Basic Medical SciencesChinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical CollegeBeijingChina
  2. 2.Center for AIDS, Institute of Pathogen BiologyChinese Academy of Medical Sciences and School of Peking Union Medical CollegeBeijingChina
  3. 3.National Influenza CenterChinese Center for Disease Control and PreventionBeijingChina
  4. 4.Center for Molecular Immunology, Institute of MicrobiologyChinese Academy of SciencesBeijingChina

Personalised recommendations